Advanced search
Publication Cover
Biomarkers in Medicine Volume 17, 2023 - Issue 8
Submit an article Journal homepage
576
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Serum CDC42 Reflects the Exacerbation Risk and Severity, Th1/2 Cell Imbalance and Inflammation in Asthmatic Children

Ning Yang1 Department of Pediatrics, Infection & Digestion, Xingtai People's Hospital, Xingtai, Hebei, 054031, China
,
Jielin Gao2 Department of Pediatric Rehabilitation, Xingtai People's Hospital, Xingtai, Hebei, 054031, China
,
Yanjun Han1 Department of Pediatrics, Infection & Digestion, Xingtai People's Hospital, Xingtai, Hebei, 054031, China
&
Lili Zhang3 Department of Gastroenterology, Tian Jin Dongli Hospital, Tianjin, 300300, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7232-902X
ORCID Icon
Pages 407-415 | Received 07 Jan 2023, Accepted 26 Jun 2023, Published online: 31 Jul 2023

References

  • Adachi Y , TakizawaT, FutamuraMet al. Executive summary: Japanese pediatric guideline for the treatment and management of asthma (JPGL) 2020. Allergol. Int.71(4), 472–480 (2022).
  • Devonshire AL , KumarR. Pediatric asthma: principles and treatment. Allergy Asthma Proc.40(6), 389–392 (2019).
  • Porsbjerg C , MelenE, LehtimakiL, ShawD. Asthma. Lancet401(10379), 858–873 (2023).
  • Kercsmar CM , ShippC. Management/comorbidities of school-aged children with asthma. Immunol. Allergy Clin. North Am.39(2), 191–204 (2019).
  • Cloutier MM , DixonAE, KrishnanJAet al. Managing asthma in adolescents and adults: 2020 asthma guideline update from the National Asthma Education and Prevention Program. JAMA324(22), 2301–2317 (2020).
  • Garner O , RameyJS, HananiaNA. Management of life-threatening asthma: severe asthma series. Chest162(4), 747–756 (2022).
  • Miller RL , GraysonMH, StrothmanK. Advances in asthma: new understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management. J. Allergy Clin. Immunol.148(6), 1430–1441 (2021).
  • Reddel HK , BacharierLB, BatemanEDet al. Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes. Eur. Respir. J.59(1), 2102730 (2022).
  • Tan LD , NguyenN, AlismailA, CastroM. Management of uncontrolled asthma: a framework for novel and legacy biologic treatments. J. Asthma Allergy15, 875–883 (2022).
  • Fergeson JE , PatelSS, LockeyRF. Acute asthma, prognosis, and treatment. J. Allergy Clin. Immunol.139(2), 438–447 (2017).
  • Leung JS . Paediatrics: how to manage acute asthma exacerbations. Drugs Context10, https://doi.org/10.7573/dic.2020-12-7 (2021).
  • Saxena S , Rosas-SalazarC, FitzpatrickA, BacharierLB. Biologics and severe asthma in children. Curr. Opin. Allergy Clin. Immunol.23(2), 111–118 (2023).
  • Reyes-Miguel T , Roa-EspitiaAL, Baltierrez-HoyosR, Hernandez-GonzalezEO. CDC42 drives RHOA activity and actin polymerization during capacitation. Reproduction160(3), 393–404 (2020).
  • Pichaud F , WaltherRF, Nunesde Almeida F. Regulation of CDC42 and its effectors in epithelial morphogenesis. J. Cell Sci.132(10), jcs217869 (2019).
  • Yang JQ , KalimKW, LiYet al. Rational targeting CDC42 restrains Th2 cell differentiation and prevents allergic airway inflammation. Clin. Exp. Allergy49(1), 92–107 (2019).
  • Zhang W , HuangY, WuY, GunstSJ. A novel role for RhoA GTPase in the regulation of airway smooth muscle contraction. Can. J. Physiol. Pharmacol.93(2), 129–136 (2015).
  • Zhang X , XieL, FangX. Cell division cycle 42 reflects disease risk, symptoms, Th1/Th2 disproportion, and its short-term variation indicates symptom amelioration after treatment in allergic rhinitis patients. J. Clin. Lab. Anal.36(10), e24684 (2022).
  • Asthma GIf . Global strategy for asthma management and prevention. Fundamentals of numerical reservoir simulation (2012).
  • Fu LS , TsaiMC. Asthma exacerbation in children: a practical review. Pediatr. Neonatol.55(2), 83–91 (2014).
  • Pumputiene I , EmuzyteR, SiaurysA, TamosiunasV, ValiulisA. CD4+CD25 (high) Treg cells in peripheral blood during remission and exacerbation of allergic asthma in children. Acta Paediatr.100(7), 1006–1010 (2011).
  • Ma X , LiuH, ZhuJet al. miR-185-5p regulates inflammation and phagocytosis through CDC42/JNK pathway in macrophages. Genes (Basel)13(3), 468 (2022).
  • Bekhouche B , TourvilleA, RavichandranYet al. A toxic palmitoylation of CDC42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome. J. Allergy Clin. Immunol.146(5), 1201–1204.e8 (2020).
  • Steinke JW , BorishL. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir. Res.2(2), 66–70 (2001).
  • Sharma V , CowanDC. Obesity, inflammation, and severe asthma: an update. Curr. Allergy Asthma Rep.21(12), 46 (2021).
  • Zhang N , XuJ, JiangC, LuS. Neuro-immune regulation in inflammation and airway remodeling of allergic asthma. Front. Immunol.13, 894047 (2022).
  • Zhang B , ZhangJ, XiaLet al. Inhibition of CDC42 reduces macrophage recruitment and suppresses lung tumorigenesis in vivo. J. Recept. Signal Transduct. Res.41(5), 504–510 (2021).
  • Li C , XuMM, WangKet al. Macrophage polarization and meta-inflammation. Transl. Res.191, 29–44 (2018).

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.